Toggle Main Menu Toggle Search

Open Access padlockePrints

Severe Cholestasis Predicts Recurrent Primary Sclerosing Cholangitis Following Liver Transplantation

Lookup NU author(s): Professor Derek Manas, Gourab Sen

Downloads


Licence

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND).


Abstract

Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology. Background & Aims: Primary sclerosing cholangitis (PSC) may reoccur following liver transplantation (LT) and the diagnosis established once imaging studies demonstrate the diagnostic cholangiographic appearance. To evaluate whether the development of recurrent PSC (rPSC) is associated with cholestasis soon after LT, we studied whether changes in hepatic biochemistry within the first 12 months were linked with the development of rPSC and graft loss. Methods: We conducted a retrospective cohort analysis of 158 transplant recipients with PSC in Canada, and 549 PSC transplant recipients from the United Kingdom. We evaluated serum liver tests within 12 months after LT and the subsequent development of a cholangiographic diagnosis of rPSC as a time-dependent covariate using Cox regression. Severe cholestasis was defined as either alkaline phosphatase> 3xupper limit of normal or total bilirubin> 100 mol/L. Results: Patients who developed rPSC were more likely to have severe cholestasis versus those without at 3 months (20.5% vs 8.2%, p=0.011), at 6 months (17.9% vs. 10.0%, p=0.026) and 12 months (15.4% vs. 7.8%, p=0.051) in the Canadian cohort and at 12 months in the UK cohort (27.9% vs. 12.6%, p<0.0001). By multivariable analysis, development of severe cholestasis in the Canadian cohort at 3 months (HR=2.41, p=0.046) and in the UK cohort at 12 months (HR=3.141, p<0.0001) were both associated with rPSC. Severe cholestasis at 3 months in the Canadian cohort was predictive of graft loss (HR=3.88, p=0.0001). Conclusions: The development of cholestasis within 3 to 12 months following LT was predictive of rPSC and graft loss.


Publication metadata

Author(s): Aziz B, Kok B, Cheah M, Lytvyak E, Moctezuma-Velazquez C, Wasilenko S, Tsochatzis E, Ravikumar R, Jose S, Allison M, Gunson B, Manas D, Monaco A, Mirza D, Fusai G, Owen N, Thorburn D, Roberts K, Srinivasan P, Wigmore S, Athale A, Creamer F, Fernando B, Iyer V, Madanur M, Sen G, Montano-Loza AJ, Hansen B, Mason AL

Publication type: Article

Publication status: Published

Journal: American Journal of Gastroenterology

Year: 2024

Pages: ePub ahead of Print

Online publication date: 25/07/2024

Acceptance date: 09/05/2024

Date deposited: 06/08/2024

ISSN (print): 0002-9270

ISSN (electronic): 1572-0241

Publisher: Wolters Kluwer Health

URL: https://doi.org/10.14309/ajg.0000000000002977

DOI: 10.14309/ajg.0000000000002977

PubMed id: 39052775


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
Canadian Institutes for Health Research
Canadian National Transplant Research Program
Canadian Liver Foundation

Share